JMP and SAS: Technology Behind RBM Analytics
In mid-July, the SAS Press Program released a new book titled Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS.
In mid-July, the SAS Press Program released a new book titled Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS. The book is written by Richard C. Zink, Principal Research Statistician Developer in the JMP Life Sciences division at SAS Institute. He is currently a developer for JMP Clinical, a software package designed to streamline the review of clinical trial data.
In this blog, Zink discusses how important data quality is, however, “a significant proportion of trial costs in the pharmaceutical industry are associated with the review of trial data. The goal is to maintain high quality data with more efficient review, leveraging statistics and graphics as much as possible.”
The book is geared toward clinical trial teams interested in taking an analytical and proactive approach to data quality and safety to streamline clinical development activities and address shortcomings throughout a study.
